Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...
In one of the most closely-watched arenas in biotech, Intellia says its gene editing treatment for a heart muscle ...
Trogenix has emerged from stealth to advance its pipeline of viral immunotherapies for cancer, starting with a lead candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback